Cargando…
MicroRNA-184 Modulates Doxorubicin Resistance in Osteosarcoma Cells by Targeting BCL2L1
BACKGROUND: Early metastasis of osteosarcoma (OS) is highly lethal and responds poorly to drug and radiation therapies. MicroRNAs (miRNAs) are a class of small noncoding RNAs that modulate gene expression at the post-transcriptional level. However, the detailed functions of specific miRNAs are not e...
Autores principales: | Lin, Bo-chuan, Huang, Dong, Yu, Chao-qun, Mou, Yong, Liu, Yuan-hang, Zhang, Da-wei, Shi, Feng-jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917317/ https://www.ncbi.nlm.nih.gov/pubmed/27222034 http://dx.doi.org/10.12659/MSM.896451 |
Ejemplares similares
-
A comprehensive analysis for associations between multiple microRNAs and prognosis of osteosarcoma patients
por: Yang, Wen, et al.
Publicado: (2020) -
Pharmacological inhibition of Bcl-xL sensitizes osteosarcoma to doxorubicin
por: Baranski, Zuzanna, et al.
Publicado: (2015) -
Expression of microRNA-184 in glioma
por: Wu, Xiao-Ben, et al.
Publicado: (2018) -
Regulatory effects of microRNA-184 on osteosarcoma via the Wnt/β-catenin signaling pathway
por: Du, Zhenguang, et al.
Publicado: (2018) -
ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells
por: Parrondo, Ricardo, et al.
Publicado: (2013)